Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block
1 other identifier
interventional
90
1 country
1
Brief Summary
The perioperative management of pain following lower abdominal surgery can pose a challenge to anesthesia providers. Conventional practice has involved the use of opioids as well as neuraxial analgesic techniques. Unfortunately, these therapies are not without potential risks and side effects. These include nausea, vomiting, pruritus, urinary retention, constipation, respiratory depression, and sedation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2018
CompletedFirst Posted
Study publicly available on registry
December 19, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedOctober 18, 2021
October 1, 2021
10 months
December 16, 2018
October 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
first analgesic request
first time to call for analgesia
24 hours
Study Arms (3)
Group B
EXPERIMENTALPatients will receive Levobupivacaine 5%
Group D
ACTIVE COMPARATORPatients will receive Levobupivacaine 5% + 1 µg/kg dexmedetomedine .
Group F
ACTIVE COMPARATORPatients will receive Levobupivacaine 5% + 1µg/kg fentanyl
Interventions
Patients will receive Levobupivacaine 5%
Patients will receive Levobupivacaine 5% + 1 µg/kg dexmedetomedine
Eligibility Criteria
You may qualify if:
- ASA physical status II-III,
- scheduled for uncomplicated elective paraumbilical hernia repair.
You may not qualify if:
- Patient refusal to participate in the study
- Patients with coagulopathy or under anticoagulation therapy.
- Infection near the site of needle insertion.
- Body mass index \> 40kg/m2
- Patients with any neurological or neuromuscular disorder or history of seizures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut governorate
Asyut, Egypt
Related Publications (5)
Elvir-Lazo OL, White PF. The role of multimodal analgesia in pain management after ambulatory surgery. Curr Opin Anaesthesiol. 2010 Dec;23(6):697-703. doi: 10.1097/ACO.0b013e32833fad0a.
PMID: 20847690BACKGROUNDWhite PF, Kehlet H. Improving postoperative pain management: what are the unresolved issues? Anesthesiology. 2010 Jan;112(1):220-5. doi: 10.1097/ALN.0b013e3181c6316e. No abstract available.
PMID: 20010418BACKGROUNDSharma P, Chand T, Saxena A, Bansal R, Mittal A, Shrivastava U. Evaluation of postoperative analgesic efficacy of transversus abdominis plane block after abdominal surgery: A comparative study. J Nat Sci Biol Med. 2013 Jan;4(1):177-80. doi: 10.4103/0976-9668.107286.
PMID: 23633858BACKGROUNDMcDonnell JG, O'Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The analgesic efficacy of transversus abdominis plane block after abdominal surgery: a prospective randomized controlled trial. Anesth Analg. 2007 Jan;104(1):193-7. doi: 10.1213/01.ane.0000250223.49963.0f.
PMID: 17179269BACKGROUNDAditianingsih D, Mochtar CA, Chandra S, Sukmono RB, Soamole IW. Comparison of Three-Quadrant Transversus Abdominis Plane Block and Continuous Epidural Block for Postoperative Analgesia After Transperitoneal Laparoscopic Nephrectomy. Anesth Pain Med. 2018 Sep 3;8(5):e80024. doi: 10.5812/aapm.80024. eCollection 2018 Oct.
PMID: 30533391BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
December 16, 2018
First Posted
December 19, 2018
Study Start
January 1, 2019
Primary Completion
November 1, 2019
Study Completion
December 1, 2019
Last Updated
October 18, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share